Sign inGet started

Radhakrishnan Karthik

Insider CIK 1573327 · OPXA Chief Financial Officer · MNPR Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
MNPR Monopar Therapeutics P Buy2024-10-282024-10-301,550$16.25 $25.2K1,550SEC↗
MNPR Monopar Therapeutics A Award deriv2024-07-012024-07-03125,000— $0125,000SEC↗
OPXA Opexa Therapeutics, Inc. M Exercise deriv2015-04-082015-04-0950,000— $050,000SEC↗
OPXA Opexa Therapeutics, Inc. M Exercise deriv2015-04-082015-04-0950,000— $00SEC↗
OPXA Opexa Therapeutics, Inc. M Exercise2015-04-082015-04-0950,000— $0124,659SEC↗
OPXA Opexa Therapeutics, Inc. A Award deriv2015-03-022015-03-0450,000— $050,000SEC↗
OPXA Opexa Therapeutics, Inc. A Award deriv2014-02-282014-03-0464,625— $064,625SEC↗
OPXA Opexa Therapeutics, Inc. A Award2014-02-282014-03-0416,659— $074,659SEC↗
OPXA Opexa Therapeutics, Inc. P Buy2013-12-182013-12-188,000$1.70 $13.6K58,000SEC↗
OPXA Opexa Therapeutics, Inc. P Buy2013-08-082013-08-0950,000$1.50 $75.0K50,000SEC↗
OPXA Opexa Therapeutics, Inc. A Award deriv2013-03-292013-04-01125,000— $0125,000SEC↗